Foghorn Therapeutics  logo
Foghorn Therapeutics FHTX
$ 5.0 0.4%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Foghorn Therapeutics ROCE Ratio 2011-2024 | FHTX

Annual ROCE Ratio Foghorn Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
139.79 -104586.61 -103.99 -46.88 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
139.79 -104586.61 -26149.42

Quarterly ROCE Ratio Foghorn Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
328.96 274.4 153.39 230.22 114.04 -31.91 -158.13 -215.86 -248.29 -164.54 -125.58 -73.23 -85.88 -66.1 -54.4 -32.67 -17.78 9.75 20.38 14.88 14.88 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
328.96 -248.29 -5.4